Targeting placental growth factor (PIGF), a pro-angiogenic cytokine, reduces tumor growth, angiogenesis and metastasis and enhances chemotherapy (gemcitabine or cyclophosphamide) and anti-VEGF therapy efficacy in melanoma or pancreatic tumor models. The gene discussed is VEGFA; the disease is neoplasm.